Brent Miller, Ph.D., PMP, CA-AM
Vice President of Product & Portfolio Management
R. Brent Miller, Ph.D., PMP, CA-AM, serves as Vice President of Product and Portfolio Management at NeuroTrauma Sciences. Brent has more than 25 years of drug development experience that spans start-up companies, including MDS Tricon; mid-size pharma companies, including Upsher-Smith Laboratories, Bausch & Lomb Pharmaceuticals, and Bio-Research; and large pharma companies, including Johnson & Johnson and Fujisawa (now Astellas Pharma). Throughout this experience, he has led a wide variety of operational departments, including Technical Strategic Alliances, Project Management, Pharmaceutical Sciences (Formulation Development/Analytical Development), Bioanalytical Development, and Quality Control and Stability. Brent oversees NeuroTrauma’s Project Management and CMC departments, critical functions as the company advances its pipeline through manufacturing and regulatory hurdles and explores technical strategic alliances. Brent received his B.Sc. (Specialization in Chemistry) from the University of Alberta, in Edmonton, Canada and his Ph.D. from the University of Oklahoma, where he focused on bioanalytical neurochemistry. He is a frequent invited speaker/panelist at conferences and has 29 publications in peer-reviewed journals.